ストックスクリーナーアプリを入手
37.93
2.36%
0.9864
前日終値:
$36.94
開ける：
$36.55
24時間の取引高:
6.44M
Relative Volume:
1.02
時価総額：
$14.18B
収益：
$4.99B
当期純損益:
$-5.87B
株価収益率:
-4.0563
EPS:
-9.35
ネットキャッシュフロー:
$-3.98B
1週間 パフォーマンス:
-4.93%
1か月 パフォーマンス:
-29.72%
6か月 パフォーマンス:
-73.69%
1年 パフォーマンス:
-50.99%
1日の値動き範囲:
$35.96
$38.82
1週間の範囲:
$35.80
$39.77
52週間の値動き範囲:
$35.80
$170.47
Moderna Inc Stock (MRNA) Company Profile
MRNA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| MRNA | 37.87 | 14.18B | 4.99B | -5.87B | -3.98B | -9.35 |
| VRTX | 449.80 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 747.38 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 591.88 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.12 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 107.49 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Moderna Inc Stock (MRNA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-09-13 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2024-09-13 | ダウングレード | Jefferies | Buy → Hold |
| 2024-09-13 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2024-08-28 | アップグレード | HSBC Securities | Reduce → Hold |
| 2024-08-07 | アップグレード | Deutsche Bank | Sell → Hold |
| 2024-08-05 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-02-26 | ダウングレード | HSBC Securities | Hold → Reduce |
| 2024-01-02 | アップグレード | Oppenheimer | Perform → Outperform |
| 2023-11-29 | 開始されました | Canaccord Genuity | Hold |
| 2023-11-03 | アップグレード | HSBC Securities | Reduce → Hold |
| 2023-11-02 | ダウングレード | Deutsche Bank | Hold → Sell |
| 2023-08-04 | ダウングレード | TD Cowen | Outperform → Market Perform |
| 2023-08-03 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2023-07-24 | 開始されました | William Blair | Mkt Perform |
| 2023-07-14 | 開始されました | HSBC Securities | Reduce |
| 2023-06-26 | アップグレード | UBS | Neutral → Buy |
| 2023-04-26 | 開始されました | Guggenheim | Neutral |
| 2023-03-13 | アップグレード | TD Cowen | Market Perform → Outperform |
| 2023-03-02 | 開始されました | RBC Capital Mkts | Outperform |
| 2023-02-24 | ダウングレード | SVB Securities | Market Perform → Underperform |
| 2022-12-19 | アップグレード | Jefferies | Hold → Buy |
| 2022-12-14 | ダウングレード | Chardan Capital Markets | Buy → Neutral |
| 2022-10-21 | アップグレード | SVB Leerink | Underperform → Mkt Perform |
| 2022-09-08 | アップグレード | Deutsche Bank | Hold → Buy |
| 2022-02-01 | アップグレード | Redburn | Sell → Neutral |
| 2022-01-26 | アップグレード | Deutsche Bank | Sell → Hold |
| 2022-01-21 | アップグレード | BofA Securities | Underperform → Neutral |
| 2022-01-21 | 開始されました | UBS | Neutral |
| 2021-12-07 | 開始されました | Cowen | Market Perform |
| 2021-11-09 | 開始されました | Wolfe Research | Outperform |
| 2021-10-22 | 開始されました | Deutsche Bank | Sell |
| 2021-10-15 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2021-08-06 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2021-08-06 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2021-07-15 | 繰り返されました | Jefferies | Hold |
| 2021-02-01 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2020-12-16 | ダウングレード | Jefferies | Buy → Hold |
| 2020-12-16 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-09 | ダウングレード | Needham | Buy → Hold |
| 2020-11-23 | 開始されました | Wells Fargo | Equal Weight |
| 2020-11-17 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2020-09-08 | ダウングレード | SVB Leerink | Mkt Perform → Underperform |
| 2020-07-23 | 開始されました | SVB Leerink | Mkt Perform |
| 2020-07-20 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2020-07-13 | 開始されました | Jefferies | Buy |
| 2020-06-30 | 開始されました | Argus | Buy |
| 2020-06-08 | 開始されました | Barclays | Overweight |
| 2020-04-30 | 開始されました | BMO Capital Markets | Outperform |
| 2020-03-05 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2019-12-03 | 再開されました | BofA/Merrill | Buy |
| 2019-10-25 | 開始されました | ROTH Capital | Buy |
| 2019-04-05 | 開始されました | Chardan Capital Markets | Buy |
すべてを表示
Moderna Inc (MRNA) 最新ニュース
Moderna, Inc. (NASDAQ:MRNA) Shares Purchased by John G Ullman & Associates Inc. - MarketBeat
Moderna Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
US CDC expects COVID and RSV levels to increase in coming weeks - Marketscreener.com
FY2025 EPS Estimates for Moderna Decreased by Analyst - MarketBeat
Moderna Stock Rises on Q3 Earnings & Sales Beat, Reiterates View - MSN
Moderna initiated with a Hold at Berenberg - Yahoo Finance
Moderna's stock decline after RFK Jr's appointment makes an "attractive entry point": Piper Sandler - MSN
Moderna Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
BioNTech started at buy, Moderna at hold by Berenberg (NASDAQ:BNTX) - Seeking Alpha
Today's Top Stocks: HSIC, Moderna, Uber and More - Baystreet.ca
Berenberg Bank Initiates Coverage on Moderna (NASDAQ:MRNA) - MarketBeat
Hsbc Global Res Upgrades Moderna (NASDAQ:MRNA) to Strong-Buy - MarketBeat
HSBC upgrades Moderna to Buy on pipeline potential - Yahoo Finance
BioNTech and Moderna at vanguard of new treatment wavebut which is best? - Proactive Investors UK
MODERNA : Berenberg sticks Neutral - Marketscreener.com
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Metagenomi - GlobeNewswire Inc.
Health Care Flat After Last Week's SelloffHealth Care Roundup - Marketscreener.com
Moderna Inc. stock outperforms competitors on strong trading day - MarketWatch
Moderna Remains Confident Despite Political Concerns Over Vaccine Safety and HHS Nomination - AOL
10 Biggest Biotechnology Companies - Investopedia
Moderna (NASDAQ:MRNA) Sees Strong Trading VolumeHere's What Happened - MarketBeat
Moderna (NASDAQ:MRNA) Receives "Overweight" Rating from Piper Sandler - MarketBeat
Moderna (NASDAQ:MRNA) Raised to Buy at HSBC - MarketBeat
Analyst recommendations: Biogen, HP, Moderna, Shell... - Marketscreener.com
KBC Group NV Cuts Stock Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Moderna, Inc. (NASDAQ:MRNA) Receives Average Rating of "Hold" from Analysts - MarketBeat
Wolfe Research Initiates Coverage of Moderna (MRNA) with Underperform Recommendation - MSN
Health Care Down as RFK Fears Mount -- Health Care Roundup - Marketscreener.com
Moderna Inc. stock underperforms Friday when compared to competitors - MarketWatch
Pfizer, Moderna, BioNTech Take A Beating After Trump Taps Kennedy To Head Up HHS - Yahoo! Voices
Moderna, Pfizer pharma stock dips after RFK Jr. nominated to lead HHS - Healthcare Brew
Moderna Shares Are Dipping Today: What's Going On? - Benzinga
Health stocks are tumbling after Trump's appointment of vaccine skeptic RFK Jr. - Markets Insider
Moderna (NASDAQ:MRNA) Shares Gap DownTime to Sell? - MarketBeat
Moderna, Inc. (MRNA): Among 12 High Growth Large Cap Stocks to Buy Now - Yahoo Finance
First Week of July 2025 Options Trading For Moderna (MRNA) - Nasdaq
Moderna, Novavax stocks slide after Trump nominates Robert F. Kennedy Jr. to be top health official - Yahoo Finance
RFK Jr vow to purge FDA sets up collision with Big Pharma - Reuters.com
Moderna continues to be the most shorted among S&P 500 healthcare stocks in October - Seeking Alpha
Moderna, Lily, Novavax, and Pfizer stocks fall after Trump nominates RFK Jr. as health secretary - Fast Company
This is the One Reason Moderna, Novavax, and Drug Stocks Slumped - Baystreet.ca
Moderna (NASDAQ:MRNA) Coverage Initiated by Analysts at Wolfe Research - MarketBeat
WHO Calls Vaccines 'Absolutely Critical' As Trump's Appointment Of RFK Jr Pulls Pzifer, Moderna Stocks Downhill - Benzinga
Moderna, Novovax stocks slide after Trump nominates Robert F. Kennedy Jr. to be top health official - Yahoo Finance
Trump Taps Vaccine Skeptic RFK Jr. to Lead HHS. Moderna, Novavax Stock Slide. - Barron's
Moderna, Novavax Shares Slip After Trump Names RFK Jr. Health Chief Nominee - Wall Street Pit
Palantir, Moderna, Pfizer, Alibaba, Tesla: Why These 5 Stocks Are On Investors' Radars Today - Benzinga
Moderna, Pfizer Stocks Fall After Reports of RFK Jr. Nomination - The Wall Street Journal
Health Care Down Amid RFK Fears -- Health Care Roundup - Marketscreener.com
12 High Growth Large Cap Stocks to Buy Now - Insider Monkey
Vaccine-maker stocks like Moderna, Pfizer drop as Trump taps RFK Jr. to lead HHS - MarketWatch
Moderna Inc (MRNA) 財務データ
収益
当期純利益
現金流量
EPS
0.42%
1.80%
大文字化:
|
ボリューム (24 時間):